Stay updated on Pimavanserin Relapse Prevention Clinical Trial

Sign up to get notified when there's something new on the Pimavanserin Relapse Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pimavanserin Relapse Prevention Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-03-03T22:18:34.000Z thumbnail image
  4. Check
    31 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    6%
    Check dated 2025-02-10T09:42:57.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T07:22:39.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-19T22:05:00.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.
    Difference
    1.0%
    Check dated 2025-01-12T17:34:31.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T22:36:29.000Z thumbnail image

Stay in the know with updates to Pimavanserin Relapse Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pimavanserin Relapse Prevention Clinical Trial page.